Suchergebnisse - "Farag, Basant"

PubPharm (9)

1

Facile one-pot synthesis and in silico study of new heterocyclic scaffolds with 4-pyridyl moiety : Mechanistic insights and X-ray crystallographic elucidation

enthalten in: Heliyon | 2024

von Abdelrazek, F. | Zaki, M. | Al-Hussain, S. | +8

2

Green Biocatalyst for Ultrasound-Assisted Thiazole Derivatives : Synthesis, Antibacterial Evaluation, and Docking Analysis

enthalten in: ACS omega | 2024

von Hussein, A. | Gomha, S. | El-Ghany, N. | +6

3

Synthesis of Bis-thiazoles Tethered 1,4-Dihydropyridine and Pyridine Linkers via Simple Oxidation and their Molecular Docking as VEGFR -TK Inhibitors

enthalten in: Current medicinal chemistry | 2024

von Al-Humaidi, J. | Riyadh, S. | Farag, B. | +3

4

Chitosan-sulfonic acid-catalyzed green synthesis of naphthalene-based azines as potential anticancer agents

enthalten in: Future medicinal chemistry | 2024

von Alzahrani, A. | Gomha, S. | Zaki, M. | +3

5

Mechanochemical Synthesis and Molecular Docking Studies of New Azines Bearing Indole as Anticancer Agents

enthalten in: Molecules (Basel, Switzerland) | 2023

von Ibrahim, M. | Farag, B. | Al-Humaidi, J. | +3

6

Synthesis and in vitro study of pyrimidine-phthalimide hybrids as VEGFR2 inhibitors with antiproliferative activity

enthalten in: Future medicinal chemistry | 2023

von Shehta, W. | Agili, F. | Farag, B. | +4

7

Design, synthesis and antitumor activity of novel pyran-functionalized uracil derivatives : docking studies

enthalten in: Future medicinal chemistry | 2023

von Shehta, W. | Agili, F. | Farag, B. | +4

8

Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase

enthalten in: Molecules (Basel, Switzerland) | 2023

von Abolibda, T. | Fathalla, M. | Farag, B. | +2

9

Synthesis, Molecular Docking and Anticancer Activity of Some 5‐Aryl‐5,10‐dihydropyrido[2,3‐ d:6,5‐ d′]dipyrimidine‐2,4,6,8‐tetraone Derivatives and Pyrido[2,3‐ d]pyrimidines

enthalten in: ChemistrySelect | 2022

von Farag, B. | Agili, F. | El‐Kalyoubi, S. | +3

1
[1]